| Primary |
| Hypocalcaemia |
28.9% |
| Mineral Supplementation |
7.9% |
| Anticoagulant Therapy |
5.3% |
| Drug Use For Unknown Indication |
5.3% |
| Electrolyte Substitution Therapy |
5.3% |
| Hyperkalaemia |
5.3% |
| Parenteral Nutrition |
5.3% |
| Product Used For Unknown Indication |
5.3% |
| Prophylaxis |
5.3% |
| Blood Calcium Abnormal |
2.6% |
| Blood Calcium Decreased |
2.6% |
| Convulsion Neonatal |
2.6% |
| Hypocalcemia |
2.6% |
| Hypophosphataemia |
2.6% |
| Immune System Disorder |
2.6% |
| Muscle Spasms |
2.6% |
| Parathyroidectomy |
2.6% |
| Pseudomonas Infection |
2.6% |
| Supplementation Therapy |
2.6% |
|
| Product Quality Issue |
18.4% |
| Medication Error |
12.2% |
| Product Contamination |
10.2% |
| Calcinosis |
6.1% |
| Product Compounding Quality Issue |
6.1% |
| Suspected Transmission Of An Infectious Agent Via Product |
6.1% |
| Wheezing |
6.1% |
| Necrosis |
4.1% |
| Overdose |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Wrong Technique In Drug Usage Process |
4.1% |
| Deep Vein Thrombosis |
2.0% |
| Electrocardiogram Low Voltage |
2.0% |
| Extravasation |
2.0% |
| Hypercalcaemia |
2.0% |
| Hyperphosphataemia |
2.0% |
| Hypoglycaemia |
2.0% |
| Hypoparathyroidism |
2.0% |
| Hypophagia |
2.0% |
| Incorrect Dose Administered |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
31.2% |
| Product Used For Unknown Indication |
13.5% |
| Parenteral Nutrition |
10.6% |
| Pneumonia |
5.2% |
| Sedation |
4.3% |
| Rectal Cancer |
3.5% |
| B Precursor Type Acute Leukaemia |
3.1% |
| Premedication |
3.1% |
| Antibiotic Therapy |
2.6% |
| Adverse Drug Reaction |
2.5% |
| Pyrexia |
2.5% |
| Hypocalcaemia |
2.4% |
| Hypotension |
2.4% |
| Total Parenteral Nutrition |
2.4% |
| Infection |
2.1% |
| Constipation |
1.9% |
| Hypoparathyroidism |
1.9% |
| Hypothyroidism |
1.9% |
| Hypertension |
1.5% |
| Tumour Lysis Syndrome |
1.4% |
|
| Toxic Epidermal Necrolysis |
25.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
11.1% |
| Oxygen Saturation Decreased |
8.1% |
| Post Procedural Complication |
7.1% |
| Transplant Rejection |
6.1% |
| Hyperhidrosis |
5.1% |
| Cholestasis |
4.0% |
| Hypercalcaemia |
3.0% |
| Medication Error |
3.0% |
| Renal Impairment |
3.0% |
| Respiratory Distress |
3.0% |
| Skin Necrosis |
3.0% |
| Tongue Oedema |
3.0% |
| Vomiting |
3.0% |
| Death |
2.0% |
| Disseminated Intravascular Coagulation |
2.0% |
| Fluid Overload |
2.0% |
| Hyperkalaemia |
2.0% |
| Incorrect Dose Administered |
2.0% |
| Pulmonary Embolism |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
29.5% |
| Rheumatoid Arthritis |
5.4% |
| Prophylaxis |
5.1% |
| Pain |
3.4% |
| Hypertension |
3.4% |
| Osteoporosis |
2.9% |
| Adverse Event |
2.3% |
| Premedication |
2.3% |
| Nausea |
2.1% |
| Multiple Sclerosis |
1.7% |
| Vitamin Supplementation |
1.5% |
| Depression |
1.3% |
| Multiple Myeloma |
1.3% |
| Medical Diet |
1.3% |
| Anxiety |
1.2% |
| Breast Cancer |
1.2% |
| Non-small Cell Lung Cancer |
1.2% |
| Colon Cancer |
1.1% |
| Crohn's Disease |
1.1% |
|
| Vomiting |
13.8% |
| Weight Decreased |
11.4% |
| Weight Increased |
6.0% |
| Thrombocytopenia |
5.8% |
| Pyrexia |
5.2% |
| Septic Shock |
5.1% |
| Sepsis |
4.9% |
| Urinary Tract Infection |
4.9% |
| Renal Failure Acute |
4.5% |
| Pneumonia |
4.2% |
| Renal Failure |
3.9% |
| Rash |
3.8% |
| White Blood Cell Count Decreased |
3.6% |
| Respiratory Failure |
3.5% |
| Pharmaceutical Product Complaint |
3.4% |
| Death |
3.2% |
| Nausea |
3.2% |
| Tremor |
3.2% |
| Syncope |
3.1% |
| Tachycardia |
3.1% |
|
